In contrast, when we characterized methylation of CpG sites in the gene body and the CTCF binding site of the gene targeted by beads 14 and 15, we found that hypermethylation of these CpG sites correlated with a better survival outcome of melanoma patients (Fig. 6). This evidence concerns the gene CTCF and melanoma.